Cargando…
Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine
Herein, we report the case of a 22-year-old woman with hereditary spherocytosis (HS) whose condition worsened after administration of the coronavirus disease 2019 (COVID-19), mRNA vaccine ‘BNT162b2 Pfizer-BioNTech.’ The woman had been diagnosed with HS in 2005, and her condition remained stable unti...
Autores principales: | Nomura, Jun, Seki, Masafumi, Abe, Syori, Kobayashi, Tadahiro, Okitsu, Yoko, Fukuhara, Noriko, Takahashi, Shinichiro, Harigae, Hideo, Kameoka, Junichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012938/ https://www.ncbi.nlm.nih.gov/pubmed/36625832 http://dx.doi.org/10.1080/21645515.2023.2165381 |
Ejemplares similares
-
Genotype-degree of hemolysis correlation in hereditary spherocytosis
por: Shi, Yimeng, et al.
Publicado: (2023) -
Hereditary Spherocytosis
por: Huq, Sayeeda, et al.
Publicado: (2010) -
Hereditary spherocytosis and allied disorders
por: Russo, Roberta, et al.
Publicado: (2019) -
Expression profiling of ETO2-regulated miRNAs in erythroid cells: Possible influence on miRNA abundance()
por: Fujiwara, Tohru, et al.
Publicado: (2013) -
Extramedullary paraspinal hematopoiesis in hereditary spherocytosis
por: Gogia, P., et al.
Publicado: (2008)